Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    



Trial Tests Implantable Device to Ease GERD


 
Dr. Michael Vaezi (Left) talks with patient Buz Harrison, who is taking part in a clinical trial of an implantable neurostimulator to treat gastroesophageal reflux disease (GERD). (Photo by Anne Rayner-Vanderbilt)

For more than a dozen years Buz Harrison, a Nashville-based media producer, has been plagued by gastroesophageal reflux disease (GERD).

The frequent leakage of stomach acid into his esophagus damaged his vocal cords to the point that he had to drop out of his church choir. He's tried acid-blocking medications. "But I can still feel that burning sensation," he said.

Harrison, 61, recently became one of the first three subjects at Vanderbilt University Medical Center (VUMC) to participate in a clinical trial of an implantable neurostimulator made by EndoStim, a medical device company based in Dallas and the Netherlands.

As many as 100 million Americans suffer from reflux disease, said Michael Vaezi, MD, PhD, professor of Medicine and director of the Vanderbilt Swallowing and Esophageal Disorders Center who is leading the study. Nearly a third of them continue to experience symptoms despite medical treatment.

Reflux often results from a weak or dysfunctional lower esophageal sphincter (LES) muscle between the stomach and esophagus. Implanted under the skin, the EndoStim device sends intermittent electrical pulses -- too low to be felt -- via electrodes to the LES. The goal is to strengthen the muscle and thus reduce reflux.

Called the Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) trial, the study is randomized and double-blinded, meaning that half the subjects will be randomly assigned to a control group in which the device initially will not transmit electrical signals.

Neither the subjects nor the researchers will know which group they're in. After six months, the device will be turned on in the control group.

Approximately 25 subjects are being recruited for the Vanderbilt trial, which is expected to take about a year to complete. If the neurostimulator works in Harrison's case, it may not take that long for him to get back to singing in the choir.

"Once you stop the acid that's coming up," Vaezi said, "the vocal cord is amazing in its ability to heal itself."

For more information about the LESS GERD trial, contact Tina Higginbotham, MPA, in the Division of Gastroenterology, Hepatology and Nutrition at tina.higginbotham@vanderbilt.edu.

 
Share:

Related Articles:


Recent Articles

Breakfast Celebrating the Women to Watch Class of 2017 Huge Success

Nashville Medical News' Women to Watch 2017 Breakfast celebrating 10 incredible women making a difference in healthcare was a sold out event.

Read More

HIT Parade: News from Healthcare's Tech Sector

Read More

Trial Tests Implantable Device to Ease GERD

For more than a dozen years Buz Harrison, a Nashville-based media producer, has been plagued by gastroesophageal reflux disease (GERD).

Read More

VUMC Studying Potential Approach to Reverse Precancerous Stomach Lesions

Vanderbilt University Medical Center (VUMC) cancer researcher James Goldenring, MD, PhD, has received a two-year, $200,000 grant from the DeGregorio Family Foundation in Pleasantville, New York, to begin clinical trials of a potential approach for reversing precancerous stomach lesions.

Read More

Attention Now Turns to the Senate for Healthcare Reform

On May 15, the American Medical Association (AMA) urged Senate leaders to keep in mind patients at risk of losing their insurance coverage. "Significant changes to the ACA or Medicaid program potentially threaten the ability for millions of Americans to obtain and retain coverage. It is these citizens, constituents, and patients who should be at the center of this debate," wrote AMA CEO James L. Madara, MD.

Read More

The New Face of Aesthetic Medicine

Aesthetic medicine procedures have become increasingly popular, but not all procedures ... or practices ... are created equal.

Read More

Pioneering Sexual Health

Meharry professor Dr. Kevin Billups is a pioneer in the field of men's health.

Read More

Moving at Light Speed

No longer the stuff of science fiction, lasers and radio frequency are improving skin care one patient at a time.

Read More

Disappearing Ink

When that really awesome tattoo isn't so awesome anymore, patients now have access to new technology that makes removal much easier.

Read More

Something to Smile About

Receding gum lines can damage more than self-esteem, but a procedure now available in Nashville is offering hope to patients suffering from a common dental concern.

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: